Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

519
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
519
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

3.1K
The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
3.1K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

564
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
564

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Impact of Metabolic and Endocrine Disturbance on Endometrial Function in Polycystic Ovary Syndrome.

International journal of molecular sciences·2025
Same author

Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement.

Internal medicine journal·2025
Same author

Menopause depression: Under recognised and poorly treated.

The Australian and New Zealand journal of psychiatry·2024
Same author

The role of ultrasonography in the management of post-partum haemorrhage associated with retained products of conception: A case report.

Australasian journal of ultrasound in medicine·2021
Same author

RBC motion and the basis of ultrasound Doppler instrumentation.

Australasian journal of ultrasound in medicine·2017
Same author

Absent fetal hand: a case report.

Australasian journal of ultrasound in medicine·2017

Related Experiment Video

Updated: Mar 7, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

1.5K

Low PAPP-A: what are the clinical implications?

Harmonie Lau1, Chaminda Amarasekara1, Talat Uppal1

  • 1Northern Beaches Maternity Manly Hospital Manly New South Wales 2095 Australia.

Australasian Journal of Ultrasound in Medicine
|February 14, 2017
PubMed
Summary

Ultrasound and Doppler confirm impaired placentation by assessing fetal growth and umbilical arteries. Confirmation of fetal wellbeing is recommended at 28-30 weeks if PAPP-A levels are below the first centile.

Keywords:
PAPP‐Amaternal serum

More Related Videos

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
06:04

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease

Published on: February 9, 2016

22.3K
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.7K

Related Experiment Videos

Last Updated: Mar 7, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

1.5K
Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
06:04

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease

Published on: February 9, 2016

22.3K
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.7K

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine
  • Diagnostic Imaging

Background:

  • Impaired placentation poses risks to fetal development and wellbeing.
  • Early detection of placental dysfunction is crucial for timely intervention.
  • Fetal biometry and Doppler assessments are key diagnostic tools.

Observation:

  • Ultrasound and pulsed Doppler can identify signs of impaired placentation.
  • Fetal biometry provides information on growth patterns.
  • Umbilical artery Doppler velocimetry reflects placental resistance.

Findings:

  • Combined ultrasound and Doppler assessments aid in confirming impaired placentation.
  • Low PAPP-A levels (below the first centile) are associated with placental issues.
  • Confirmation of fetal wellbeing is advised between 28-30 weeks gestation.

Implications:

  • Early identification enables closer monitoring of at-risk pregnancies.
  • Targeted interventions can potentially improve fetal outcomes.
  • This approach supports evidence-based management of placental insufficiency.